Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningTissue DonorsBone and BonesGraft SurvivalTransplantation ChimeraHistocompatibility TestingBone Marrow PurgingKidney TransplantationBusulfanHematopoietic Stem CellsHistocompatibilityLiver TransplantationBone Marrow DiseasesCyclophosphamideTransplantation, IsogeneicImmunosuppressive AgentsGraft RejectionRecurrenceHematopoiesisCombined Modality TherapyTime FactorsHematologic NeoplasmsTreatment OutcomeMice, Inbred C57BLLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationRadiation ChimeraImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsRetrospective StudiesSurvival AnalysisCytomegalovirus InfectionsHepatic Veno-Occlusive DiseaseRemission InductionGraft vs Host ReactionHeart TransplantationCyclosporineAcute DiseaseLymphocyte DepletionTransplantation ImmunologyLeukemia, MyeloidLymphoma, Non-HodgkinColony-Forming Units AssayHLA AntigensT-LymphocytesLeukocyte TransfusionStem Cell TransplantationMyelodysplastic SyndromesSurvival RateLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematologic DiseasesFollow-Up StudiesChimeraBone RemodelingSevere Combined ImmunodeficiencyFlow CytometryNuclear FamilyDisease-Free SurvivalActuarial AnalysisCell DifferentiationLymphocyte TransfusionMice, Inbred BALB COpportunistic InfectionsPrognosisImmunocompromised HostLeukocyte CountFatal OutcomePancytopeniaTransplantationBreast NeoplasmsAntineoplastic AgentsNeoplasmsSpleenCells, CulturedCell ProliferationAntilymphocyte SerumGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectMultiple MyelomaLymphomaAntibodies, MonoclonalBone DensityOrgan TransplantationGraft vs Leukemia EffectCytarabinePostoperative ComplicationsMelphalan